Showing results (211-220 of 605) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|September 28, 2021
Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi ArabiaAhmed Alghamdi, Bander Balkhi, Abdulaziz Altowaijri, et al.
Pharmacoeconomics - Open|February 20, 2022
Differences in Breast Cancer Costs by Cancer Stage and Biomarker Subtype in New ZealandChunhuan Lao, Mohana Mondal, Marion Kuper-Hommel, et al.
Pharmacoeconomics - Open|October 17, 2018
Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United StatesJill A Bell, Aaron Galaznik, Marlo Blazer, et al.
Pharmacoeconomics - Open|October 17, 2018
Working with Patients and Members of the Public: Informing Health Economics in Child Health ResearchRebecca Kandiyali, Annie Hawton, Christie Cabral, et al.
Pharmacoeconomics - Open|April 27, 2022
Cost Effectiveness of Subcutaneous Vedolizumab for Maintenance Treatment of Ulcerative Colitis in CanadaElisabetta Fenu, Vasily Lukyanov, Annabel Acs, et al.
Pharmacoeconomics - Open|March 22, 2022
Cost-Effectiveness of Constraint-Induced Movement Therapy Implementation in Neurorehabilitation: The ACTIveARM ProjectLauren J Christie, Nicola Fearn, Annie McCluskey, et al.
Pharmacoeconomics - Open|September 5, 2018
The Psychometric Properties of a Self-Administered, Open-Source Module for Valuing Metastatic Epidural Spinal Cord Compression UtilitiesMarkian Pahuta, Aaron Frombach, Emile Hashem, et al.
Pageof 61